ArticleAnnals of translational medicine2017

Gefitinib with pemetrexed as first-line therapy in patients with advanced nonsquamous non-small cell lung cancer with activating epidermal growth factor receptor mutations.

Shinkyo Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.